Results 191 to 200 of about 281,124 (345)
Advances in the mechanisms of extracellular vesicles and circulating tumor cells in hepatocellular carcinoma metastasis (Review). [PDF]
Yi S, Liu W, Wang Z.
europepmc +1 more source
ABSTRACT Prostate cancer (PCa) is the second most frequently diagnosed malignancy among men and the sixth leading cause of cancer‐related mortality worldwide. Radical prostatectomy remains the standard treatment for localized disease; however, approximately one‐third of patients develop biochemical recurrence within 10 years. Although prostate‐specific
Juliana Ramos Chaves +7 more
wiley +1 more source
Clopidogrel therapy in acute coronary syndrome: Contemporary issues
Satyavir Yadav, Rakesh Yadav
doaj +1 more source
Detection of circulating tumor cells in cholangiocarcinoma via epithelial-mesenchymal transition markers and their application. [PDF]
Liu Y +6 more
europepmc +1 more source
Temporal Dynamics of Parkinson's Disease Tremor: Clinical and Neuroimaging Insights
Abstract Background Parkinson's disease (PD) is a progressive neurodegenerative disorder clinically defined by three cardinal motor symptoms: bradykinesia, rigidity, and tremor. Although the natural history of bradykinesia and rigidity is well described, the evolution of tremor as the disease progresses remains controversial. Objectives The goal was to
Melanie Suette +15 more
wiley +1 more source
Locally synthesized glycyl aminoacyl-tRNA synthetase is important for local translation in neurons. [PDF]
de Leon TB +3 more
europepmc +1 more source
ABSTRACT Microfluidic affinity‐based capture of extracellular vesicles (EVs) holds great promise for disease diagnostics and monitoring therapeutic EV production. However, optimizing microfluidic channel geometries for efficient EV capture remains understudied due to the effort required to experimentally test numerous designs.
Arvin Lim +6 more
wiley +1 more source
Circulating tumor cell detection in cancer patients using in-flow deep learning holography. [PDF]
Mallery K +23 more
europepmc +1 more source

